Our technology is revolutionizing radiology. We’d love to work with you to help create better outcomes for patients everywhere.
We created the first FDA-cleared device supports concurrent reading, allowing for faster reading with proven, superior, automatic nodule detection.
Our four FDA-cleared applications are designed to improve reading efficiency and accuracy across the hospital enterprise without requiring additional hardware.
Riverain’s deep learning AI technology is FDA cleared, field tested, and clinically proven to provide real results in radiology.
Riverain Technologies advanced AI imaging software is in use by leading healthcare organizations around the world.
Peer reviews, reference accounts, and independent studies confirm that ClearRead technology is positively impacting the field of radiology.
Riverain Technologies is happy to announce that Jonathan Chung, MD, has accepted a clinical advisor position. Dr. Chung, Professor of Radiology; Chief of Cardiothoracic Imaging, and Chief Quality Officer in Radiology at the University of Chicago Medicine, specializes in cardiopulmonary imaging. He has authored over 140 peer-reviewed articles that have been published in scientific journals, co-authored five book chapters and five books that focus on chest diagnostics. He has practiced Radiology since 2010.
“We are extremely pleased to welcome Dr. Chung to Riverain’s clinical advisory board to help drive our leading solutions in thoracic radiology. Dr. Chung’s depth and breadth of knowledge will be a tremendous asset for Riverain going forward,” stated Steve Worrell, CEO.